Review Article
Changes in the maternal cytokine profile in pregnancies complicated by fetal growth restriction
Edward Mullins,
Tomas Prior,
Irene Roberts,
Sailesh Kumar,
Edward Mullins
Queen Charlotte's and Chelsea Hospital, Imperial College, London, UK
Search for more papers by this authorTomas Prior
Queen Charlotte's and Chelsea Hospital, Imperial College, London, UK
Search for more papers by this authorIrene Roberts
Hammersmith Hospital and Imperial College, London, UK
Search for more papers by this authorCorresponding Author
Sailesh Kumar
Queen Charlotte's and Chelsea Hospital, Imperial College, London, UK
*Correspondence
Sailesh Kumar, Centre for Fetal Care, Queen Charlotte's and Chelsea Hospital, Ducane Road, London, W12 OHS, UK
E-mail. [email protected]
Search for more papers by this authorEdward Mullins,
Tomas Prior,
Irene Roberts,
Sailesh Kumar,
Edward Mullins
Queen Charlotte's and Chelsea Hospital, Imperial College, London, UK
Search for more papers by this authorTomas Prior
Queen Charlotte's and Chelsea Hospital, Imperial College, London, UK
Search for more papers by this authorIrene Roberts
Hammersmith Hospital and Imperial College, London, UK
Search for more papers by this authorCorresponding Author
Sailesh Kumar
Queen Charlotte's and Chelsea Hospital, Imperial College, London, UK
*Correspondence
Sailesh Kumar, Centre for Fetal Care, Queen Charlotte's and Chelsea Hospital, Ducane Road, London, W12 OHS, UK
E-mail. [email protected]
Search for more papers by this authorAbstract
Fetal growth restriction (FGR) is an important and poorly understood condition of pregnancy, which results in significant fetal, neonatal and long-term morbidity and mortality. The aetiology of FGR is unknown and is likely to result from sub-optimal placental implantation and feto-maternal immunological interaction. The diagnostic criteria for FGR vary between studies, and the condition often occurs with preeclampsia (PET). We present a review of studies of maternal cytokines in FGR and compare these with studies of Small for Gestational Age and PET pregnancies.
References
- 1 Damodaram M, Story L, Kulinskaya E, Rutherford M, Kumar S: Early adverse perinatal complications in preterm growth-restricted fetuses. Aust N Z J Obstet Gynaecol 2011; 51: 204–209.
- 2 Soothill P, Nicolaides K, Campbell S: Prenatal asphyxia, hyperlacticaemia, hypoglycaemia, and erythroblastosis in growth retarded fetuses. Br Med J (Clin Res Ed) 1987; 294: 1051–1053.
- 3 Ferro-Luzzi A, Ashworth A, Martorell R, Scrimshaw N: Report of the IDECG Working Group on effects of IUGR on infants, children and adolescents: immunocompetence, mortality, morbidity, body size, body composition, and physical performance. Eur J Clin Nutr 1998; 52: S97–S99.
- 4 Baschat AA, Harman CR, Gembruch U: Haematological consequences of placental insufficiency. Arch Dis Child Fetal Neonatal Ed 2004; 89: F94.
- 5
Watts T, Roberts I: Haematological abnormalities in the growth-restricted infant. Semin Neonatol 1999; 4: 41–54.
10.1016/S1084-2756(99)80006-2 Google Scholar
- 6 Walker D-M, Marlow N, Upstone L, Gross H, Hornbuckle J, Vail A, Wolke D, Thornton JG: The Growth Restriction Intervention Trial: long-term outcomes in a randomized trial of timing of delivery in fetal growth restriction. Am J Obstet Gynecol 2011; 204: 34.e31–34.e39.
- 7 Brosens I, Dixon H, Robertson W: Fetal growth retardation and the arteries of the placental bed. Br J Obstet Gynaecol 1977; 84: 656–663.
- 8 Wegmann TG, Lin H, Guilbert L, Mosmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14: 353–356.
- 9 Piccinni M-P, Scaletti C, Maggi E, Romagnani S: Role of hormone-controlled Th1- and Th2-type cytokines in successful pregnancy. J Neuroimmunol 2000; 109: 30–33.
- 10 Marzi M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, Clerici E, Clerici M: Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996; 106: 127–133.
- 11 Hahn-Zoric M, Hagberg H, Kjellmer I, Ellis J, Wennergren M, Hanson LA: Aberrations in Placental Cytokine mRNA Related to Intrauterine Growth Retardation. Pediatr Res 2002; 51: 201–206.
- 12 Johnson MR, Anim-Nyame N, Johnson P, Sooranna SR, Steer PJ: Does endothelial cell activation occur with intrauterine growth restriction? BJOG 2002; 109: 836–839.
- 13 Bartha JL, Romero-Carmona R, Comino-Delgado R: Inflammatory cytokines in intrauterine growth retardation. Acta Obstet Gynecol Scand 2003; 82: 1099–1102.
- 14 Street ME, Seghini P, Fieni S, Ziveri MA, Volta C, Martorana D, Viani I, Gramellini D, Bernasconi S: Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. Eur J Endocrinol 2006; 155: 567–574.
- 15 Raghupathy R, Al-Azemi M, Azizieh F: Intrauterine Growth Restriction: Cytokine Profiles of Trophoblast Antigen-Stimulated Maternal Lymphocytes. Clin Dev Immunol 2012; doi:10.1155/2012/734865.
- 16 Heyborne KD, McGregor J, Henry G, Witkin SS, Abrams JS: Interleukin-10 in amniotic fluid at midtrimester: immune activation and suppression in relation to fetal growth. Am J Obstet Gynecol 1994; 171: 55–59.
- 17 Amu S, Hahn-Zoric M, Malik A, Ashraf R, Zaman S, Kjellmer I, Hagberg H, Padyukov L, Hanson LÅ: Cytokines in the Placenta of Pakistani Newborns With and Without Intrauterine Growth Retardation. Pediatr Res 2006; 59: 254–258.
- 18 Schipper E-JI, Bolte AC, Schalkwijk CG, Van Geijn HP, Dekker GA: TNF-receptor levels in preeclampsia – results of a longitudinal study in high-risk women. J Matern Fetal Neonatal Med 2005; 18: 283–287.
- 19 Holcberg G, Huleihel M, Sapir O, Katz M, Tsadkin M, Furman B, Mazor M, Myatt L: Increased production of tumor necrosis factor-α TNF-α by IUGR human placentae. Eur J Obst Gynecol Reprod Biol 2001; 94: 69–72.
- 20 Laskowska M, Leszczyńska-Gorzelak B, Laskowska K, Oleszczuk J: Evaluation of maternal and umbilical serum TNFα levels in preeclamptic pregnancies in the intrauterine normal and growth-restricted fetus. J Matern Fetal Neonatal Med 2006; 19: 347–351.
- 21 Laskowska M, Laskowska K, Leszczyńska-Gorzelak B, Oleszczuk J: Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation. J Matern Fetal Neonatal Med 2007; 20: 527–532.
- 22 Spong CY, Sherer DM, Ghidini A, Jenkins CB, Seydel FD, Eglinton GS: Second-trimester amniotic fluid or maternal serum interleukin-10 levels and small for gestational age neonates. Obstet Gynecol 1996; 88: 24–28.
- 23 Georgiou HM, Thio YS, Russell C, Permezel M, Heng YJ, Lee S, Tong S: Association between maternal serum cytokine profiles at 7-10 weeks' gestation and birthweight in small for gestational age infants. Am J Obstet Gynecol 2011; 204: 415.e411–415.e412.
- 24 Kimya Y, Akdiş C, Cengiz C, Ozan H, Tatlikazan S, Uncu G, Şengül F: Plasma interleukin-1α, interleukin-1β and interleukin-1 receptor antagonist levels in pre-eclampsia. Eur J Obst Gynecol Reprod Biol 1997; 73: 17–21.
- 25 Szarka A, Rigó J Jr, Lázár L, Beko G, Molvarec A: Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunology 2010; 11: doi:10.1186/1471-2172-11-59.
- 26 Eneroth E, Remberger M, Vahlne A, Ringden O: Increased serum concentrations of interleukin-2 receptor in the first trimester in women who later developed severe preeclampsia. Acta Obstet Gynecol Scand 1998; 77: 591–593.
- 27 Madazli R, Aydin S, Uludag S, Vildan O, Tolun N: Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels. Acta Obstet Gynecol Scand 2003; 82: 797–802.
- 28 Kaleli I, Kaleli B, Demir M, Yildirim B, Cevahir N, Demir S: Serum levels of neopterin and interleukin-2 receptor in women with severe preeclampsia. J Clin Lab Anal 2005; 19: 36–39.
- 29 Martorell R, Ramakrishnan U, Schroeder D, Melgar P, Neufeld L: Intrauterine growth retardation, body size, body composition and physical performance in adolescence. Eur J Clin Nutr 1998; 52: S43–S52.
- 30 Bernardi F, Guolo F, Bortolin T, Petronilho F, Dal-Pizzol F: Oxidative stress and inflammatory markers in normal pregnancy and preeclampsia. J Obstet Gynaecol Res 2008; 34: 948–951.
- 31 Freeman DJ, McManus F, Brown EA, Cherry L, Norrie J, Ramsay JE, Clark P, Walker ID, Sattar N, Greer IA: Short- and Long-Term Changes in Plasma Inflammatory Markers Associated With Preeclampsia. Hypertension 2004; 44: 708–714.
- 32 Kronborg CS, Gjedsted J, Vittinghus E, Hansen TK, Allen JIM, Knudsen UB: Longitudinal measurement of cytokines in pre-eclamptic and normotensive pregnancies. Acta Obstet Gynecol Scand 2011; 90: 791–796.
- 33 Jonsson Y, Rubèr M, Matthiesen L, Berg G, Nieminen K, Sharma S, Ernerudh J, Ekerfelt C: Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J Reprod Immunol 2006; 70: 83–91.
- 34 Sharma A, Satyam A, Sharma JB: Leptin, IL-10 and Inflammatory Markers (TNF-α, IL-6 and IL-8) in Pre-Eclamptic, Normotensive Pregnant and Healthy Non-Pregnant Women. Am J Reprod Immunol 2007; 58: 21–30.
- 35 Kalinderis M, Papanikolaou A, Kalinderi K, Ioannidou E, Giannoulis C, Karagiannis V, Tarlatzis BC: Elevated Serum Levels of Interleukin-6, Interleukin-1β and Human Chorionic Gonadotropin in Pre-eclampsia. Am J Reprod Immunol 2011; 66: 468–475.
- 36 Casart YC, Tarrazzi K, Camejo MI: Serum levels of interleukin-6, interleukin-1β and human chorionic gonadotropin in pre-eclamptic and normal pregnancy. Gynecol Endocrinol 2007; 23: 300–303.
- 37 Vitoratos N, Economou E, Iavazzo C, Panoulis K, Creatsas G: Maternal Serum Levels of TNF-Alpha and IL-6 Long after Delivery in Preeclamptic and Normotensive Pregnant Women. Mediators Inflamm 2010; doi:10.1155/2010/908649.
- 38 Mori T, Shinohara K, Wakatsuki A, Watanabe K, Fujimaki A: Adipocytokines and endothelial function in preeclamptic women. Hypertens Res 2010; 33: 250–254.
- 39 Guven MA, Coskun A, Ertas IE, Aral M, Zencırcı B, Oksuz H: Association of Maternal Serum CRP, IL-6, TNF-α, Homocysteine, Folic Acid and Vitamin B12 Levels with the Severity of Preeclampsia and Fetal Birth Weight. Hypertens Pregnancy 2009; 28: 190–200.
- 40 Singh A, Sharma D, Raghunandan C, Bhattacharjee J: Role of Inflammatory Cytokines and eNOS Gene Polymorphism in Pathophysiology of Pre-Eclampsia. Am J Reprod Immunol 2010; 63: 244–251.
- 41 Velzing-Aarts FV, Muskiet FAJ, Van Der Dijs FPL, Duits AJ: High Serum Interleukin-8 Levels in Afro-Caribbean Women with Pre-eclampsia. Relations with Tumor Necrosis Factor-α, Duffy Negative Phenotype and Von Willebrand Factor. Am J Reprod Immunol 2002; 48: 319–322.
- 42 Hayashi M, Ueda Y, Yamaguchi T, Sohma R, Shibazaki M, Ohkura T, Inaba N: Tumor Necrosis Factor-α in the Placenta is not Elevated in Pre-eclamptic Patients Despite its Elevation in Peripheral Blood. Am J Reprod Immunol 2005; 53: 113–119.
- 43 Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WH, Hale EA, Martin Jr JN, Bennett WA: Expression of the placental cytokines tumor necrosis factor α, interleukin 1β, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol 1999; 181: 915–920.
- 44 Veenstra van Nieuwenhoven AL, Moes H, Jan Heineman M, Santema J, Faas MM: Cytokine Production by Monocytes, NK Cells, and Lymphocytes Is Different in Preeclamptic Patients as Compared with Normal Pregnant Women*. Hypertens Pregnancy 2008; 27: 207–224.
- 45 Lockwood CJ, Yen C-F, Basar M, Kayisli UA, Martel M, Buhimschi I, Buhimschi C, Huang SJ, Krikun G, Schatz F: Preeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells. Am J Pathol 2008; 172: 1571–1579.
- 46 Luppi P, DeLoia JA: Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines. Clin Immunol 2006; 118: 268–275.
- 47 Benyo DF, Smarason A, Redman CWG, Sims C, Conrad KP: Expression of Inflammatory Cytokines in Placentas from Women with Preeclampsia. J Clin Endocrinol Metab 2001; 86: 2505–2512.
- 48 Heikkinen J, Mottonen M, Pulkki K, Lassila O, Alanen A: Cytokine levels in midtrimester amniotic fluid in normal pregnancy and in the prediction of pre-eclampsia. Scand J Immunol 2001; 53: 310–314.
- 49 Zhao S, Gu Y, Dong Q, Fan R, Wang Y: Altered Interleukin-6 Receptor, IL-6R and gp130, Production and Expression and Decreased SOCS-3 Expression in Placentas from Women with Pre-eclampsia. Placenta 2008; 29: 1024–1028.
- 50 Hadlock FP, Harrist RB, Sharman RS, Park SK: Estimation of fetal weight with the use of head, body, and femur measurements–a prospective study. Am J Obstet Gynecol 1985; 151: 333–337.
- 51 Bakheit KH, Bayoumi NK, Eltom AM, Elbashir MI, Adam I: Cytokines Profiles in Sudanese Women with Preeclampsia. Hypertens Pregnancy 2009; 28: 224–229.
- 52 Borekci B, Aksoy H, Al RA, Demircan B, Kadanali S: Maternal Serum Interleukin-10, Interleukin-2 and Interleukin-6 in Pre-Eclampsia and Eclampsia. Am J Reprod Immunol 2007; 58: 56–64.
- 53 Makris A, Xu B, Yu B, Thornton C, Hennessy A: Placental Deficiency of Interleukin-10 (IL-10) in Preeclampsia and its Relationship to an IL10 Promoter Polymorphism. Placenta 2006; 27: 445–451.
- 54 Hennessy A, Pilmore HL, Simmons LA, Painter DM: A Deficiency of Placental IL-10 in Preeclampsia. J Immunol 1999; 163: 3491–3495.
- 55 Djurovic S, Clausen T, Wergeland R, Brosstad F, Berg K, Henriksen T: Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia. BJOG 2002; 109: 759–764.
- 56 Santner-Nanan B, Peek MJ, Khanam R, Richarts L, Zhu E, Fazekas de St Groth B, Nanan R: Systemic Increase in the Ratio between Foxp3+ and IL-17-Producing CD4+ T Cells in Healthy Pregnancy but Not in Preeclampsia. J Immunol 2009; 183: 7023–7030.
- 57 Redman CW, Sacks GP, Sargent IL: Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180: 499–506.
